In partnership with the University of Oxford, OSI invests in fundamental technology companies, built on science. We match Oxford’s scientists with experienced entrepreneurs to turn idea to impact, discovery to company.
Congratulations to our portfolio company, Scenic Biotech, on their strategic partnership with @Genentech to discover, develop and commercialise novel therapeutics that target genetic modifiers. Read more about the deal that could exceed $375m @endpts: https://endpts.com/roche-looks-to-genetic-modifiers-for-new-drug-targets-teaming-up-with-dutch-biotech-in-375m-deal/
Welcome to Dr Carsten Reinhard who joins the board at @theolytics. This world-class team are harnessing Darwin's natural selection theory to create viruses capable of combatting cancer #biotech #bioinformatics #science #innovation
Theolytics Announces Appointment of Immatics’ Carsten Reinhardt to its Board of Directors'.
https://www.theolytics.com/news/theolytics-announces-appointment-of-immatics-carsten-reinhardt-to-its-board-of-directors/
We are looking for an ambitious, talented and creative Associate for Investor Relations and Co-Investors. This is a varied and exciting role, apply now! #hiring #science #innovation #VentureCapital #oxford
https://www.linkedin.com/jobs/view/2011688196/?refId=1708851201600418093500
OSI // A thousand years of the future.
For all enquiries: hello@oxfordsciences.com
Address
46 Woodstock Road,
Oxford, OX2 6HT
United Kingdom
© Oxford Sciences Innovation 2020
